公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 14 | 13 | |
2021 | Hyaluronan-Loaded Liposomal Dexamethasone-Diclofenac Nanoparticles for Local Osteoarthritis Treatment | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; Chen, Kuan-Yin; YING-CHENG CHIANG | International journal of molecular sciences | 29 | 22 | |
2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 31 | 29 | |
2019 | Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center | YI-JOU TAI ; HENG-CHENG HSU ; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | International Journal of Environmental Research and Public Health | 9 | 8 | |
2014 | Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study | Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG ; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; WEN-FANG CHENG | Gynecologic Oncology | 29 | 26 | |
2011 | Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma | YU-LI CHEN ; Ho C.-M.; CHI-AN CHEN ; YING-CHENG CHIANG ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecology and Obstetrics | 6 | 6 | |
2021 | Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis | YEN-LING LAI ; CHUN-JU CHIANG ; YU-LI CHEN ; You, San-Lin; Chen, Yun-Yuan; YING-CHENG CHIANG ; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEN-FANG CHENG | Cancer medicine | 3 | 3 | |
2018 | Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment | Chang M.-C.; YU-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; Hsieh S.-F.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Molecular Therapy | 31 | 28 | |
2022 | Leiomyomatosis peritonealis disseminata in laparoscopic port site and abdomino-pelvic cavity: A case report | Hsieh, Yun-Chiao; Kuo, Po-Yen; YING-CHENG CHIANG | Radiology case reports | 2 | 0 | |
2012 | A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors | Sun H.-D.; Lin H.; Jao M.-S.; Wang K.-L.; Liou W.-S.; Hung Y.-C.; YING-CHENG CHIANG ; Lu C.-H.; Lai H.C.; Yu M.-H. | Gynecologic Oncology | 90 | 82 | |
2014 | Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma | Huang H.-N.; Lin M.-C.; Huang W.-C.; YING-CHENG CHIANG ; KUAN-TING KUO | Modern Pathology | 66 | 60 | |
2017 | Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A taiwanese gynecologic oncology group (TGOG) study | Chiang A.-J.; Chen M.-Y.; Weng C.-S.; Lin H.; Lu C.-H.; Wang P.-H.; Huang Y.-F.; YING-CHENG CHIANG ; Yu M.-H.; Chang C.-L. | Journal of Gynecologic Oncology | 36 | 28 | |
2012 | Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways | Chang M.-C.; CHI-AN CHEN ; Chen P.-J.; YING-CHENG CHIANG ; YU-LI CHEN ; TSUI-LIEN MAO ; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG | Biochemical Journal | 113 | 112 | |
2016 | Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; Chen T.-C.; Tang Y.-C.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Gene Therapy | 16 | 16 | |
2010 | Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis | CHI-AN CHEN ; Ho C.-M.; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; Syu M.-H.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Therapy | 82 | 72 | |
2015 | Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation | Huang H.-N.; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN ; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 25 | 22 | |
2012 | New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation | Chang M.-C.; YING-CHENG CHIANG ; Ho C.-M.; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG ; Chou C.-Y. | Taiwanese Journal of Obstetrics and Gynecology | 5 | 4 | |